Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
Condition(s):Obesity; Knee Osteoarthritis; Osteoarthritis, KneeLast Updated:January 16, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Obesity; Knee Osteoarthritis; Osteoarthritis, KneeLast Updated:January 16, 2024Not yet recruiting
Condition(s):Osteoarthritis; Knee Osteoarthritis; Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic DiseasesLast Updated:May 12, 2023Recruiting
Condition(s):Knee OsteoarthritisLast Updated:March 22, 2024Recruiting
Condition(s):Knee OsteoarthritisLast Updated:February 15, 2024Recruiting
Condition(s):Chronic Pain; Central Sensitisation; Knee OsteoarthritisLast Updated:August 18, 2023Not yet recruiting
Condition(s):Knee OsteoarthritisLast Updated:February 26, 2024Recruiting
Condition(s):Knee OsteoarthritisLast Updated:March 8, 2024Recruiting
Condition(s):Knee OsteoarthritisLast Updated:October 21, 2022Not yet recruiting
Condition(s):Knee Osteoarthritis; Knee Pain ChronicLast Updated:December 20, 2023Recruiting
Condition(s):Knee OsteoarthritisLast Updated:March 5, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.